Antimicrobial Resistance [AMR] is projected to cause 1.91 million deaths annually by 2050, a 67.5% increase from 2021. More than 65% of AMR-related deaths in 2050 are expected to be among people aged 70 and older and likely will become the leading cause of death in the world surpassing even cancer. AMR may cost the global economy up to $100 trillion by 2050. AMR is an umbrella term which explains how bacteria, viruses, and other microbes [fungi] can develop resistance to medications like antibiotics, making infections harder to treat due to their ability to evade the drugs designed to kill them.This session offers 1.0 CME/CMLE credit.Faculty/Authors
Physician Competencies: Patient Care, Medical Knowledge, Systems-Based PracticeCME/CMLE Credit: 1.0 Estimated Completion Time: 1 hour Format: Online Educational Activity Accreditation Statement: The American Society for Clinical Pathology (ASCP) is accredited by the Accreditation Council for Continuing Medical Education to provide continuing medical education (CME) for physicians. This activity has been planned and implemented in accordance with the Essential Areas and Policies of the Accreditation Council for Continuing Medical Education (ACCME). Credit Designation Statement: The American Society for Clinical Pathology (ASCP) designates this journal-based CME activity for a maximum of 1 AMA PRA Category 1 Credit(s)™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.
Instructions
To claim CME/CMLE credit for the exercise, do the following:
Faculty Disclosure
Technical Considerations
Release Date: 11/18/2025Review Date:Expiration Date: